A National Institutes of Health (NIH) laboratory for the investigation of virulence factors forgotten found that there was a small amount and is not approved for treatment of dangerous bacteria and toxins forgotten lab.
Plague virus grown in petri dishes. (Source: CDC / TODD PARKER)
“Washington Post” reported that a United States National Institutes of Health (NIH) laboratory for forgotten pathogenic factor survey found that the presence of a small amount of treatment has not been approved and was forgotten dangerous bacteria and toxins in laboratories .
These samples contain two bottles of plague bacteria (Yersinia pestis), two bottles of Burkholderia pseudomallei – can cause tropical diseases melioidosis, three bottles of tularemia bacteria, two bottles of botulinum toxin and a collection date for 1914 deadly ricin. These bacteria and toxins are all located in the federal list of special agents, which means they must be registered, and only licensed laboratories to deal with these agents.
The newspaper had reported in July, the U.S. Food and Drug Administration (FDA) had not approved in a lab found Staphylococcus aureus enterotoxin (can cause food poisoning). July, people in the NIH campus in a laboratory freezer FDA found six bottles dated 1954 live smallpox virus, after which the relevant agencies to start inventory operations, cleaning NIH and other federal agencies, special agents, these findings is part of the results of the inventory action.
In the September 5 to all staff in a memo, NIH Dean Francis Collins said that these bacterial samples were all stored in the NIH Clinical Center. Burkholderia bacteria isolated from the same patient sample, while others are experimental samples.
The memorandum also mentioned ricin from castor beans have been used for biochemical terrorist attack, “legitimate laboratory can apply very sparingly,” but they have no right to use the lab. And for botulinum toxin, the public is more likely to know is that this is a forehead Botox– injectables, can eliminate wrinkles.
Collins described the findings as “a special case of a small amount of medicine improperly stored.” Fortunately, no human exposure to these bacteria and toxins, which are sealed in containers. However, Collins wrote: “The discovery of these samples showed that the biological need to follow federal safety standards, supervision and constant vigilance laboratory materials.” NIH hopes to publish a list of the status quo about the park Pharmacy in early October.